Search results for "Vaccination"

showing 10 items of 660 documents

Acceptance of SARS-CoV-2 Vaccination Among a Cohort of IBD Patients From Southern Italy: A Cross-Sectional Survey

2021

2019-20 coronavirus outbreakmedicine.medical_specialtyCOVID-19 VaccinesCoronavirus disease 2019 (COVID-19)Cross-sectional studySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Directive CounselingInternal medicineHumansImmunology and AllergyMedicineFamilyPhysician's RoleLetter to the EditorAcademicSubjects/MED00260Ibdjnl/1SARS-CoV-2business.industryGastroenterologistsVaccinationAge FactorsGastroenterologyCOVID-19Inflammatory Bowel DiseasesPatient Acceptance of Health CareInflammatory Bowel DiseasesVaccinationItalyInfluenza VaccinesCohortbusinessAttitude to HealthInflammatory Bowel Diseases
researchProduct

Urology practice during the COVID-19 vaccination campaign

2021

Introduction: The current scenario of the COVID-19 pandemic is significantly different from that of the first, emergency phase. Several countries in the world are experiencing a second, or even a third, wave of contagion, while awaiting the effects of mass vaccination campaigns. The aim of this report was to provide an update of previously released recommendations on prioritization and restructuring of urological activities. Methods: A large group of Italian urologists directly involved in the reorganization of their urological wards during the first and second phase of the pandemic agreed on a set of updated recommendations for current urology practice. Results: The updated recommendations…

2019-20 coronavirus outbreakmedicine.medical_specialtyCOVID-19 VaccinesCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronaviru030232 urology & nephrologycoronavirusmedicine.disease_causesurgery03 medical and health sciences0302 clinical medicinevaccinePandemicmedicineHumansOriginal Research Articlecoronavirus; COVID-19; pandemic; vaccine; urology; clinical practice guidelines; surgery; endourologyurologyPandemicsCoronavirusbusiness.industryImmunization ProgramsSARS-CoV-2pandemicendourologyCOVID-19General MedicineVirologySmart communication (SC173–SC181) Urinary stones: timing and assessmentVaccination030220 oncology & carcinogenesisEmergency medicineUrologic Surgical ProceduresCOVID-19; Coronavirus; clinical practice guidelines; endourology; pandemic; surgery; urology; vaccinebusinessclinical practice guidelinesclinical practice guideline
researchProduct

P463 COVID-19 vaccination willingness and hesitancy in patients with Inflammatory Bowel Diseases (IBD): analysis of determinants in a national survey…

2021

Abstract Background Vaccine hesitancy, the delay in acceptance or refusal of vaccination despite its availability, represents a threat to the diffusion and lethality of infectious diseases. COVID-19 vaccination has been recommended by national and international organizations in patients with Inflammatory Bowel Diseases (IBD). The aim of the study was to evaluate COVID-19 vaccine willingness and hesitancy in a population of Italian patients with IBD, and their determinants. Methods In February 2021 an online questionnaire focused on COVID-19 vaccine was proposed to a representative sample of Italian IBD patients. Socio-demographic characteristics, IBD features, lifestyle, perception of COVID…

2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)business.industryGastroenterologyInflammatory Bowel DiseasesGeneral MedicineClinical: Therapy and Observationmedicine.diseaseInflammatory bowel diseasePoster presentationsVaccinationVaccination RefusalFamily medicineMedicineIn patientAdverse effectbusinessAcademicSubjects/MED00260Journal of Crohn's & Colitis
researchProduct

Site-specific DBCO modification of DEC205 antibody for polymer conjugation

2018

The design of multifunctional polymer-based vectors, forming pDNA vaccines, offers great potential in cancer immune therapy. The transfection of dendritic immune cells (DCs) with tumour antigen-encoding pDNA leads to an activation of the immune system to combat tumour cells. In this work, we investigated the chemical attachment of DEC205 antibodies (aDEC205) as DC-targeting structures to polyplexes of P(Lys)-b-P(HPMA). The conjugation of a synthetic block copolymer and a biomacromolecule with various functionalities (aDEC205) requires bioorthogonal techniques to avoid side reactions. Click chemistry and in particular the strain-promoted alkyne-azide cycloaddition (SPAAC) can provide the req…

540 Chemistry and allied sciencesRAFT polymerizationpDNA polyplexvaccinationbioorthogonal chemistryArticleDEC205 antibodylcsh:QD241-441strain-promoted alkyne-azide cycloaddition (SPAAC)lcsh:Organic chemistry540 Chemiecancer immune therapydendritic cells (DCs)targeting
researchProduct

The awareness and acceptance of anti-COVID 19 vaccination in adolescence

2022

Abstract Background COVID-19 had devastating effects on children’s and adolescents’ life, including neuropsychological impairment, discontinuation of social life and education. Since June 2021, antiCOVID19 vaccination has become available to adolescents in Italy up to 12 years and since December 2021 to children aged more than 5 years. The pediatric population represents a challenging target for vaccination. Aim of the study is to perform a survey among adolescents to explore factors associated with COVID 19 immunization and their perceptions about COVID-19 vaccines. Methods Italian students aged 10–17 years were invited to participate in an anonymous online survey regarding their immunizat…

Adolescence COVID-19 Survey VaccinationGeneral Medicine
researchProduct

Pertussis vaccines--1993.

1993

AdolescentWhooping CoughJapanmedicinemedia_common.cataloged_instanceHumansEuropean UnionEuropean unionChildWhooping coughDiphtheria-Tetanus-Pertussis Vaccinemedia_commonPertussis Vaccinebusiness.industryInfant NewbornInfantDiphtheria-Tetanus-Pertussis Vaccinemedicine.diseaseInfant newbornVaccinationEuropeChild PreschoolPediatrics Perinatology and Child HealthImmunologyPertussis vaccinebusinessTos ferinamedicine.drugForecastingEuropean journal of pediatrics
researchProduct

In Vitro Priming to Tumor-Associated Proteins

1997

Cancer can be cured in mice by adoptive transfer of T cells specific for the malignant cells or by vaccination to tumor-specific antigens. The application of immunotherapy to the treatment of human cancer hinges on the identification of human tumor antigens to which specific immunity can be elicited.

Adoptive cell transferbiologybusiness.industrymedicine.medical_treatmentfungifood and beveragesPriming (immunology)ImmunotherapyDendritic cellIn vitroVaccinationAntigenmedicineCancer researchbiology.proteinbusinessKeyhole limpet hemocyanin
researchProduct

Therapeutic Vaccination of Hematopoietic Cell Transplantation Recipients Improves Protective CD8 T-Cell Immunotherapy of Cytomegalovirus Infection

2021

Reactivation of latent cytomegalovirus (CMV) endangers the therapeutic success of hematopoietic cell transplantation (HCT) in tumor patients due to cytopathogenic virus spread that leads to organ manifestations of CMV disease, to interstitial pneumonia in particular. In cases of virus variants that are refractory to standard antiviral pharmacotherapy, immunotherapy by adoptive cell transfer (ACT) of virus-specific CD8+ T cells is the last resort to bridge the “protection gap” between hematoablative conditioning for HCT and endogenous reconstitution of antiviral immunity. We have used the well-established mouse model of CD8+ T-cell immunotherapy by ACT in a setting of experimental HCT and mu…

Adoptive cell transfermedicine.medical_treatmentImmunologyCytomegalovirusCD8-Positive T-LymphocytesLymphocyte ActivationCD8+ T cellsVirusCytomegalovirus VaccinesImmunocompromised HostAntigenvaccineMHC class ImedicineImmunology and AllergyCytotoxic T cellAnimalsCells Culturedadoptive cell transferCell ProliferationOriginal ResearchHCMV dense bodiesbiologybusiness.industryVaccinationHematopoietic Stem Cell TransplantationImmunotherapyRC581-607VirologyAdoptive TransferTransplantationMice Inbred C57BLantiviral protectionT cell primingDisease Models AnimalT cell receptor transgenic cellsCytomegalovirus InfectionsHost-Pathogen Interactionsbiology.proteinFemaleVirus Activationsubviral particlesImmunologic diseases. AllergybusinessCD8Frontiers in Immunology
researchProduct

Invasive meningococcal disease in Italy: from analysis of national data to an evidence-based vaccination strategy

2020

Introduction. Invasive meningococcal disease (IMD) is one of the most severe vaccine-preventable diseases not yet under control. In Italy, although different anti-meningococcal vaccines are available, their offer among regions is heterogeneous. The aim of this study is to describe the epidemiology of IMD in Italy based on analysis of national surveillance data for 2011–2017 to optimize the vaccination strategy. Methods: IMD surveillance data from the Italian National Health Institute were analysed. Microsoft Excel was used to present trend analysis, stratifying by age and serogroups. Results: In Italy, during the period 2011–2017, the incidence of IMD increased from 0.25 cases/100,000 inhab…

AdultAdolescentDatabases FactualInvasive meningococcal diseasesEpidemiologyMeningococcal VaccinesNO03 medical and health sciencesYoung AdultInvasive meningococcal diseases • epidemiology • surveillance system • anti-meningococcal vaccination strategiesHumansChildSurveillance system0303 health sciencesEvidence-Based Medicine030306 microbiologyInvasive meningococcal diseases Epidemiology Surveillance system Anti-meningococcal vaccination strategiesIncidenceInvasive meningococcal diseaseInfantMiddle AgedMeningococcal InfectionsItalyChild PreschoolPopulation SurveillanceOriginal ArticleAnti-meningococcal vaccination strategiesanti-meningococcal vaccination strategies.Journal of Preventive Medicine and Hygiene
researchProduct

[Alert for meningitis in Palermo? Successful strategies to counteract the impact of mass media]

2018

Following two invasive meningococcal disease cases among twenties, general population overloaded vaccination Units of the Palermo's District during summer 2016. Sicilian Health Authorities adopted several public health strategies including: a) active meningococcal vaccination free of charge for people from 18 up to 30 years of age, b) information in crowded places and rapid communication by media. An increase in anti-meningococcal vaccination doses administered (+868%) as well as in anti-dTp and HPV vaccination (+41% and +8%, respectively) due to a further catch-up was observed.

AdultAdolescentVaccinationInfantMeningococcal Vaccinesinvasive meningococcal disease active meningococcal vaccination public health strategiesMeningitis MeningococcalMiddle AgedYoung AdultItalyChild PreschoolHumansMass MediaPublic HealthChildAged
researchProduct